| Print
SELLAS Life Sciences Group (SLS)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Address
60 Prescott Street
Worcester
MA
USA
01605
Telephone
+1 508 9293615
Forecast key dates
| Name | Key Date |
|---|---|
| SELLAS Life Sciences Group Inc Fourth Quarter Earnings Results for 2027 | 2027-03-19T00:00:00 |
| SELLAS Life Sciences Group Inc Annual Report for 2026 | 2027-03-19T00:00:00 |
| SELLAS Life Sciences Group Inc Third Quarter Earnings Results for 2026 | 2026-11-12T00:00:00 |
| SELLAS Life Sciences Group Inc Second Quarter Earnings Results for 2026 | 2026-08-12T00:00:00 |
| SELLAS Life Sciences Group Inc Annual General Meeting for 2026 | 2026-06-17T08:30:00 |
| SELLAS Life Sciences Group Inc First Quarter Earnings Results for 2026 | 2026-05-13T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| SELLAS Life Sciences Group Inc Fourth Quarter Earnings Results for 2026 | 2026-03-19T00:00:00 |
| SELLAS Life Sciences Group Inc Annual Report for 2025 | 2026-03-19T00:00:00 |
| SELLAS Life Sciences Group Inc Third Quarter Earnings Results for 2025 | 2025-11-12T00:00:00 |
| SELLAS Life Sciences Group Inc Second Quarter Earnings Results for 2025 | 2025-08-12T00:00:00 |
| SELLAS Life Sciences Group Inc Annual General Meeting for 2025 | 2025-06-17T08:30:00 |
| A.G.P. Virtual Healthcare Company Showcase | 2025-05-21T08:20:00 |
| SELLAS Life Sciences Group Inc First Quarter Earnings Results for 2025 | 2025-05-13T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.